{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:19:39Z","timestamp":1791944379295,"version":"4.3.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Topical steroid withdrawal (TSW) is a skin condition characterized by red burning, itchy, painful skin lesions, often accompanied by peeling, and cracking. Patients experience sleep disturbances due to intense itching, significantly impacting their quality of life. A majority of affected individuals develop secondary bacterial infection, marked by heavy colonization of <jats:italic>Staphylococcus aureus (S. aureus)<\/jats:italic> and alterations in the skin microbiome. TSW is described as a rebound effect following discontinuation of prolonged use of mid-to-high-potency topical corticosteroids. There exist no definitive diagnostic criteria for this entity, and it is often misdiagnosed as a flare-up of an underlying condition or a contact allergy. Despite numerous personal reports and experiences shared on online platforms, studies on TSW remain scarce in scientific literature. Recognizing and effectively managing this condition is critical for healthcare providers seeking to develop comprehensive management plans. These plans typically include supportive therapy for both physical and psychological symptoms, as well as the gradual tapering of corticosteroid use before complete discontinuation. This review aims to consolidate the existing knowledge on TSW, providing a comprehensive resource for its identification, management, and treatment. By enhancing understanding of TSW, this review seeks to support healthcare providers in implementing optimal management strategies and improving patient outcomes.<\/jats:p>","DOI":"10.3389\/falgy.2025.1547923","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:28:05Z","timestamp":1743398885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal"],"prefix":"10.3389","volume":"6","author":[{"given":"Anish R.","family":"Maskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sargen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Geliebter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Safai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.anai.2022.03.004","article-title":"Optimizing topical management of atopic dermatitis","volume":"128","author":"Butala","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B2","first-page":"386","article-title":"Topical corticosteroid addiction and withdrawal - an overview for GPs","volume":"45","author":"Sheary","year":"2016","journal-title":"Aust Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.anai.2022.09.031","article-title":"Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey","volume":"130","author":"Barta","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\u201csteroid addiction\u201d) in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-4362.1979.tb01905.x","article-title":"Steroid addiction","volume":"18","author":"Kligman","year":"1979","journal-title":"Int J Dermatol"},{"key":"B6","article-title":"Topical steroid withdrawal in atopic dermatitis","author":"Lio","year":"2019","journal-title":"Pract Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.NURSE.0000287732.08659.83","article-title":"Facing up to withdrawal from topical steroids","volume":"37","author":"Smith","year":"2007","journal-title":"Nursing"},{"key":"B8","article-title":"Topical steroid withdrawal - everything we know so far: TSW assist 2023","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/DHPS.S69201","article-title":"Topical steroid addiction in atopic dermatitis","volume":"6","author":"Fukaya","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"key":"B10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40261-021-01072-z","article-title":"Steroid phobia: is there a basis? A review of topical steroid safety, addiction and withdrawal","volume":"41","author":"Tan","year":"2021","journal-title":"Clin Drug Investig"},{"key":"B11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1586\/17469872.1.4.547","article-title":"The red skin syndromes: corticosteroid addiction and withdrawal","volume":"1","author":"Rapaport","year":"2006","journal-title":"Expert Rev Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/JDN.0000000000000331","article-title":"Systematic review of the topical steroid addiction and topical steroid withdrawal phenomenon in children diagnosed with atopic dermatitis and treated with topical corticosteroids","volume":"9","author":"Juh\u00e1sz","year":"2017","journal-title":"J Dermatol Nurses Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1080\/09546634.2021.1882659","article-title":"Topical corticosteroid withdrawal (\u201csteroid addiction\u201d): an update of a systematic review","volume":"33","author":"Hwang","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1142\/12519","volume-title":"Treating Eczema With Traditional Chinese Medicine","author":"Li","year":"2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4183\/aeb.2016.232","article-title":"Topical steroid induced facial rosaceiform dermatitis","volume":"12","author":"Tatu","year":"2016","journal-title":"Acta Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12886-017-0504-5","article-title":"Bilateral Morganella Morganii keratitis in a patient with facial topical corticosteroid-induced rosacea-like dermatitis: a case report","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"B17","first-page":"135","article-title":"Choosing topical corticosteroids","volume":"79","author":"Ference","year":"2009","journal-title":"Am Fam Physician"},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/0019-5154.139876","article-title":"Topical corticosteroid addiction and phobia","volume":"59","author":"Ghosh","year":"2014","journal-title":"Indian J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.anai.2022.09.005","article-title":"Topical steroid withdrawal syndrome: should we worry?","volume":"130","author":"Spergel","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B20","article-title":"Vergara J. Topical steroid ladder potency strength chart","year":""},{"key":"B21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/DER.0000000000000387","article-title":"Steroid withdrawal effects following long-term topical corticosteroid use","volume":"29","author":"Sheary","year":"2018","journal-title":"Dermatitis"},{"key":"B22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-981-16-6065-8_6","article-title":"Topical steroid damaged face in females with skin of colour","volume-title":"Skin Diseases in Females","author":"Bhat","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/jcb.23081","article-title":"Keratinocytes synthesize and activate cortisol","volume":"112","author":"Cirillo","year":"2011","journal-title":"J Cell Biochem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2010.11.059","article-title":"Steroid synthesis by primary human keratinocytes; implications for skin disease","volume":"404","author":"Hannen","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801238-3.00245-2","article-title":"Nitric oxide","volume-title":"Reference Module in Biomedical Sciences","author":"Ignarro","year":"2014"},{"key":"B27","first-page":"198","article-title":"Steroid-induced rosacealike dermatitis: case report and review of the literature","volume":"83","author":"Chen","year":"2009","journal-title":"Cutis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1163\/1568569042664521","article-title":"Nitric oxide levels in atopic dermatitis","volume":"16","author":"Akdeniz","year":"2004","journal-title":"Pain Clin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10753-021-01615-8","article-title":"Regulatory role of nitric oxide in cutaneous inflammation","volume":"45","author":"Man","year":"2022","journal-title":"Inflammation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archderm.140.8.1013","article-title":"Serum nitric oxide levels in \u201cred\u201d patients: separating corticosteroid-addicted patients from those with chronic eczema","volume":"140","author":"Rapaport","year":"2004","journal-title":"Arch Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/allergies2010001","article-title":"Could modifying the skin microbiome, diet, and lifestyle help with the adverse skin effects after stopping long-term topical steroid use?","volume":"2","author":"Wallen-Russell","year":"2021","journal-title":"Allergies"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.dsi.2015.05.002","article-title":"Barrier abnormalities and keratinocyte-derived cytokine cascade after cessation of long-term topical glucocorticosteroid on hairless mouse skin","volume":"33","author":"Lin","year":"2015","journal-title":"Dermatologica Sinica"},{"key":"B34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1592\/phco.22.5.282.33191","article-title":"Health literacy: a review","volume":"22","author":"Andrus","year":"2012","journal-title":"Pharmacotherapy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0019-5154.182417","article-title":"Topical steroid damaged\/dependent face (TSDF): an entity of cutaneous pharmacodependence","volume":"61","author":"Lahiri","year":"2016","journal-title":"Indian J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/PTT.S126727","article-title":"Drug-induced psoriasis: clinical perspectives","volume":"7","author":"Balak","year":"2017","journal-title":"Psoriasis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1468-3083.2012.04656.x","article-title":"Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?","volume":"27","author":"Mrowietz","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/DAD.0b013e3181722ef4","article-title":"Pattern analysis of drug-induced skin diseases","volume":"30","author":"Justiniano","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e060867","DOI":"10.1136\/bmjopen-2022-060867","article-title":"Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients","volume":"12","author":"Tan","year":"2022","journal-title":"BMJ Open"},{"key":"B40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.anai.2022.01.044","article-title":"Targeting the skin in atopic dermatitis","volume":"128","author":"Leung","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jdcr.2018.06.012","article-title":"Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: a retrospective case series","volume":"4","author":"Arnold","year":"2018","journal-title":"JAAD Case Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.intimp.2017.11.031","article-title":"Adverse events of dupilumab in adults with moderate-to-severe atopic dermatitis: a meta-analysis","volume":"54","author":"Ou","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaad.2024.03.039","article-title":"Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study","volume":"91","author":"Hasan","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.anai.2020.12.002","article-title":"Traditional Chinese medicine for food allergy and eczema","volume":"126","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13223-021-00555-0","article-title":"Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy","volume":"17","author":"Uzun","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cells13191639","article-title":"Berberine inhibits the inflammatory response induced by Staphylococcus aureus isolated from atopic eczema patients via the TNF-\u03b1\/inflammation\/RAGE pathways","volume":"13","author":"Maskey","year":"2024","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","first-page":"AB70","DOI":"10.1016\/j.jaci.2023.11.240","article-title":"Investigation of berberine\u2019s potential in attenuating Staphylococcus aureus-induced inflammatory responses","volume":"153","author":"Kwan","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"AB66","DOI":"10.1016\/j.jaci.2023.11.228","article-title":"Effects of multi-component TCM therapy on skin microbiome of infants with severe eczema associated with topical steroid withdrawal","volume":"153","author":"Reyes","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"208690","DOI":"10.1155\/2015\/208690","article-title":"Efficacy of acupuncture in itch: a systematic review and meta-analysis of clinical randomized controlled trials","volume":"2015","author":"Yu","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/09546634.2019.1573306","article-title":"Black tea dressings - a rapidly effective treatment for facial dermatitis","volume":"30","author":"Witte","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1172\/JCI65642","article-title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis","volume":"123","author":"van den Bogaard","year":"2013","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.25208\/0042-4609-2018-94-3-56-66","article-title":"Eczema: tactics of choice external therapy","volume":"94","author":"Zaslavsky","year":"2018","journal-title":"Vestn Dermatol Venerol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/jdv.12864","article-title":"Use of emollients in atopic dermatitis","volume":"29","author":"Ng","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1547923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:28:21Z","timestamp":1743398901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1547923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":53,"alternative-id":["10.3389\/falgy.2025.1547923"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1547923","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"1547923"}}